Estradiol and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Estradiol (estradiol) and Requip (ropinirole hydrochloride). Common drug interactions include fluid retention among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Estradiol and Requip. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Estradiol?

Estradiol has active ingredients of estradiol. It is often used in menopause. eHealthMe is studying from 18,986 Estradiol users. Check the latest studies of Estradiol.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.



On Jul, 29, 2026

55 people who take Estradiol and Requip together, and have interactions are studied.

Estradiol and Requip drug interactions.

What are the common drug interactions of Estradiol and Requip, by gender? *:

female:

  1. Fluid retention (an abnormal accumulation of fluid in the blood)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  4. Headache (pain in head)
  5. Heart rate decreased
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Joint swelling
  8. Local swelling (swelling at the site of some application of substance or injury)
  9. Loss of consciousness
  10. Memory impairment

male:

  1. Abdominal pain
  2. Adverse drug reaction
  3. Drug hypersensitivity
  4. Dyspepsia (indigestion)
  5. Feeling hot
  6. Feeling of body temperature change
  7. Heart rate decreased
  8. Hypoglycaemia (deficiency of glucose in the bloodstream)
  9. Hypotension (abnormally low blood pressure)
  10. Muscle spasms (muscle contraction)

What are the common drug interactions of Estradiol and Requip, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Adverse drug reaction
  2. Personality disorder
  3. Psychotic disorder
  4. Suicidal ideation
  5. Suicide attempt

30-39:

  1. Apnoea (suspension of external breathing)
  2. Asthma
  3. Sinus disorder (disease of sinus)
  4. Snoring

40-49:

  1. Renal vein thrombosis (blood clot in renal vein)
  2. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  3. Chronic kidney disease
  4. Abdominal discomfort
  5. Anxiety
  6. Asthma
  7. Depression
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  10. Insomnia (sleeplessness)

50-59:

  1. Drug ineffective
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Chest discomfort
  4. Cough
  5. Fatigue (feeling of tiredness)
  6. Nausea (feeling of having an urge to vomit)
  7. Pain in extremity
  8. Abdominal discomfort
  9. Arthralgia (joint pain)
  10. Chronic kidney disease

60+:

  1. Dizziness
  2. Diarrhoea
  3. Alopecia (absence of hair from areas of the body)
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Arthropathy
  8. Bacterial infection
  9. Blood creatine increased
  10. Blood glucose decreased

What are the existing conditions these people have? *

  1. High Blood Pressure: 9 people, 16.36%
  2. Depression: 8 people, 14.55%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 12.73%
  4. Pain: 7 people, 12.73%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 12.73%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 12.73%
  7. Headache (pain in head): 5 people, 9.09%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 7.27%
  9. High Blood Cholesterol: 3 people, 5.45%
  10. Diarrhea: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Estradiol and Requip?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Estradiol and Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Estradiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Estradiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Requip and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estradiol and ropinirole hydrochloride (the active ingredients of Estradiol and Requip, respectively), and Estradiol and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: